tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Cash flow

Compare
652 Followers

Urogen Pharma Cash Flow

URGN's free cash flow for Q3 2025 was $-42.36M. For the 2025 fiscal year, URGN's free cash flow was decreased by $-20.49M and operating cash flow was $-42.27M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -96.77M$ -76.38M$ -87.56M$ -84.89M$ -105.89M
Investing Cash Flow
$ -20.61M$ -953.00K$ 1.06M$ 4.07M$ 93.24M
Financing Cash Flow
$ 194.62M$ 116.93M$ 97.13M$ 72.32M$ 16.53M
End Cash Position
$ 173.06M$ 95.82M$ 56.22M$ 45.59M$ 54.09M
Free Cash Flow
$ -97.06M$ -76.57M$ -87.81M$ -85.64M$ -107.10M
Currency in USD

Urogen Pharma Cash Flow